HDAC6-IN-57
HDAC6-IN-57 (compound 9c) is an HDAC6 inhibitor with an IC50 value of 7 nM. HDAC6-IN-57 inhibits 60 cancer cell lines with a mean GI50 of 2.64 μM while exhibiting significantly lower cytotoxicity towards non-tumor cell lines[1].
Product Specifications
UNSPSC
12352005
Target
HDAC
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
O=C(NO)CCCCCCN1CC(N2[C@H](C1=O)CC3=C([C@@H]2C4=CC=CC(Br)=C4)NC5=CC=CC=C53)=O
Molecular Formula
C27H29BrN4O4
Molecular Weight
553.45
References & Citations
[1]Aya Fathy, et al. Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer. RSC Med Chem. 2025 Apr 17.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
Y051665 50 μL
Anti-Angiotensin II Receptor (AT2 Receptor) (extracellular)
Sign In for Pricing
View Details 
BNCB1083-100 1x 100 µL
Cdk1 / p34cdc2 Serine-Threonine Kinase (A17.1.1), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 